Acute Transverse Myelitis Associated with Buserelin Use during IVF
- PMID: 23607013
- PMCID: PMC3625571
- DOI: 10.1155/2013/386765
Acute Transverse Myelitis Associated with Buserelin Use during IVF
Abstract
A healthy woman undergoing in vitro fertilization (IVF) developed acute transverse myelitis (ATM) following the use of Buserelin. ATM has a multifactorial etiology and may develop as a result of the activation of immune responses. Infectious agents have been postulated as possible triggers of an immune response (Sá, 2009). Gonadotropin-releasing agonists may have a similar role and trigger the acceleration of preexisting disease by the activation of immune responses (Ho et al., 1995, and Umesaki et al., 1999).
Figures
References
-
- Barlow DH. GnRH agonists and in vitro fertilization. The Journal of Reproductive Medicine. 1998;43(supplement 3):245–251. - PubMed
-
- Jeffery DR, Mandler RN, Davis LE. Transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Archives of Neurology. 1993;50(5):532–535. - PubMed
-
- Borchers AT, Gershwin ME. Transverse myelitis. Autoimmunity Reviews. 2012;11(3):231–248. - PubMed
-
- Dunne K, Hopkins IJ, Shield LK. Acute transverse myelopathy in childhood. Developmental Medicine & Child Neurology. 1986;28:198–204. - PubMed
-
- Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA. Diagnosis and management of acute myelopathies. Neurologist. 2005;11(1):2–18. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
